Caudal Epidural Steroid and Trigger Point Injection
Myofascial Trigger Point Pain
About this trial
This is an interventional treatment trial for Myofascial Trigger Point Pain focused on measuring Caudal Epidural Steroid Injection, Trigger Point Injection, NRS score
Eligibility Criteria
Inclusion Criteria: Low back or leg pain that has been going on for at least 2 months, Patients between the ages of 18-70, Disc herniation or radiculopathy in lumbar MRI examination .To be mentally competent to understand and evaluate NRS, ODI, and SF-36 forms. exclusion criteria Being pregnant or lactating, Presence of spinal canal stenosis, The presence of bleeding diathesis, Presence of disease with progressive neurological deficit, The presence of serious psychiatric illness, Presence of progressive neurological deficit or incontinence, Having an epidural steroid injection in the last 6 months, Having uncontrolled diabetes mellitus Having hypertension, Known history of allergy to local anesthetics or corticosteroids, The patient does not want treatment, Local infection at the injection site, Infections such as discitis, spondylodiscitis, and sacroiliitis.
Sites / Locations
- Abant Izzet Baysal University Medical School,Recruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group C
Group CT
Group C; caudal epidural steroid injection (10 mL volume of bupivacaine 4cc/20mg+ triamcinolone 2cc/80mg+0.09% NaCl 4cc mixture will be administered into the caudal epidural space).
Group CT; trigger point injection will be added to the gluteus medius and minimus muscles in addition to caudal epidural steroid injection.